Platform & human science
Corporate evidence overview and the deeper source-linked BHOC repository.
Evidence & research boundaries
Follow each claim
to its source.
Historical HBOC records, external transplantation studies and the BHOC research concept are three different layers. Use the original BHOC hubs for publication-level details.
Three connected evidence routes
Choose the right source layer.
General BHOC science, veterinary history and transplantation research are related, but their evidence must not be pooled into one product claim.
Species-specific evidence
Historical veterinary carrier use, case context and regulatory sources. These cannot establish a transplant indication.
Organ-specific evidence
Historical oxygen-carrier records and separate external perfusion research, with source links and limits.
Evidence & boundaries
Follow the evidence to its source.
The BHOC evidence hub separates historical oxygen-carrier studies from external transplantation research. Neither layer establishes efficacy for the proposed BHOC Transplant program.
Preservation & perfusion
Source-linked HBOC and HBOC-201 publications provide testable context. Results depend on the named product, organ, protocol and study design.
Browse historical records ↗Organ-specific workflows
Machine perfusion, viability assessment and reperfusion research help identify where oxygen-delivery questions can be measured. Relevance is not BHOC efficacy.
Browse related evidence ↗The oxygen-release profile
Temperature, pH, oxygen gradients, oxidation and formulation must be characterized for a specific carrier. The historical P50 value is not a measured BHOC curve through cooling and rewarming.
BHOC hemoglobin context ↗Outcomes still to be tested
More useful time, gene-intervention compatibility, xenograft support and recipient healing remain distinct hypotheses requiring controlled measurements and safety data.
Research sequence ↑Research concept, not a clinical indication
BHOC Transplant proposes to study oxygen availability before, during and after transplantation, beginning with defined ex-vivo perfusion work. Donor-side and recipient-side interventions require separate authorization and evidence. The current concept does not establish BHOC-mediated gene modification, reduced rejection, stem-cell formation or faster transplantation.